CVS Health Announces Plan to Split Pharmacy Segment from Healthcare Services
CVS Health Corp. (CVS) has announced a corporate breakup plan intended to separate its retail pharmacy operations from its healthcare services and insurance arms, including Aetna and Caremark. The separation is expected to be completed by the first half of 2028. Shareholders will receive equity in both resulting entities, with the healthcare services segment retaining the CVS Health name under CEO David Joyner, while the drugstore segment, led by Prem Shah, will manage approximately 9,000 retail locations. The market reacted negatively to the news, with shares falling over 10% despite a quarterly earnings beat. Investors remain concerned regarding three primary uncertainties: how the company's $60.7 billion debt load will be allocated between the two entities, whether dividend payouts will be maintained or reduced following the split, and the long-term growth prospects of a standalone drugstore segment in a changing retail landscape.